Thymalin | Research Use Only

What it is

Thymalin is a polypeptide complex isolated from thymus tissue and studied in research settings for its immunoregulatory activity. In the scientific literature, it is described as a thymus-derived peptide preparation that regulates immune-system function, which is why it appears in immunology, hematopoiesis, and aging-related research contexts.

Origins and scientific context

Thymalin is not typically presented as a single defined peptide sequence, but rather as a thymus-derived polypeptide extract containing smaller active peptide components. Recent reviews describe thymalin as a peptide drug isolated from calf thymus, and they identify short peptides such as EW, KE, and EDP as active components discussed in mechanistic studies.

Molecular profile

Unlike many single-sequence research peptides, thymalin is generally described in the literature as a multi-component polypeptide complex rather than one discrete molecule with one universal molecular formula or molecular weight. Academic sources consistently characterize it as a thymus-derived extract, so molecular profiling is usually discussed in terms of its component peptides rather than as one standalone compound entry.

Scientific overview

In simplified terms, thymalin is used in research to study immune regulation, T-lymphocyte activity, hematopoietic differentiation, and cytokine-related signaling. Published work describes thymalin as influencing immune-cell function and hematopoietic stem-cell differentiation, which is why it is used in experimental models involving immunopathology, regeneration, and age-related immune changes.

What researchers study with Thymalin

Key research focus areas often include
• Immune-system regulation and T-cell activity
• Hematopoietic stem-cell differentiation models
• Cytokine and inflammatory-signaling pathways
• Aging-related and immunopathology research models

Regulatory and compliance notice

Research Use Only. Not for human or veterinary use. This description is provided for scientific context and must not be used to market thymalin for diagnosis, cure, mitigation, treatment, or prevention of disease.

Citations and references

Khavinson et al. The Use of Thymalin for Immunocorrection and Molecular Aspects of Its Biological Activity, review describing thymalin as a thymus-derived polypeptide drug and discussing active short-peptide components.

Kuznik et al. Peptide Drug Thymalin Regulates Immune Status in Severe COVID-19 Older Patients, paper describing thymalin as a peptide drug isolated from calf thymus and outlining its immunoprotective context.

Khavinson et al. Activation of Differentiation of Human Hematopoietic Stem Cells by Thymalin, an Immunomodulatory Peptide, paper describing thymalin as a polypeptide complex isolated from the thymus and studying hematopoietic differentiation.

Linkova et al. The Influence of KE and EW Dipeptides in the Composition of Thymalin on Gene Expression and Protein Synthesis in Human Cells, paper describing thymalin as an immunomodulatory drug containing a polypeptide extract of thymus and identifying KE and EW as active components.